{"URL": "http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGknSsXoCWRd_qTRKC_DXstdKsOoQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779224244707&ei=PNDqV6DdFY_Q3QGnyqfoDg&url=https://www.thestreet.com/story/13751964/1/apple-aapl-stock-higher-healthkit-to-provide-diagnostic-information.html", "body": "NEW YORK (TheStreet) -- Shares of Apple\u00a0 (AAPL) \u00a0were rising in early-afternoon trading on Monday as the technology company's HealthKit device is likely to begin\u00a0expand to providing analysts and diagnostic data from just tracking health information,\u00a0Bloomberg reports, citing sources.\n\nThe HealthKit app was launched in 2014 and serves as a hub for medical data, such as a user's heart rate.\n\nApple has hired numerous health care experts to enable its health software to understand the implications of patient data.\n\nThe company is also developing new health-related apps for the Apple Watch, including one that can track sleep patterns, sources said, according to\u00a0Bloomberg.\n\nLast month, Apple purchased the health care startup\u00a0Gliimpse.\u00a0Apple Health senior engineer Mohan Randhava, who previously worked at Gliimpse, said recently that he's developing a platform that's expected to be a \"disruptive consumer healthcare application.\"\n\nAdditionally,\u00a0Longbow\u00a0upped its fiscal 2017 first-quarter iPhone unit shipment estimates by 2.5 million to 81.1 million, according to\u00a0TheFly. Production trends appear to be stronger than expected, Longbow said.\n\nThe firm has a \"buy\" rating and $140 price target on Apple.\n\nApple's first quarter gross margin could beat expectations as a result of iPhone demand, positive mix changes and greater price concessions by suppliers, the firm noted.\n\nSeparately, TheStreet Ratings objectively rated this stock according to its \"risk-adjusted\" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:", "category": "tech", "title": "Apple (aapl) stock higher, healthkit to provide diagnostic information"}